Registry of ongoing Research Projects (RoPS)

Registry database of all ongoing research projects in Switzerland that are approved by the ethics committees

Lead EC
  •  Comitato etico cantonale Ticino
  •  Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD)
  •  Commission Cantonale d'éthique de la recherche Genève (CCER)
  •  Ethikkommission Nordwest- und Zentralschweiz EKNZ
  •  Ethikkommission Ostschweiz (EKOS)
  •  Kantonale Ethikkommission Bern
  •  Kantonale Ethikkommission Zürich
  • Apply
Type of project
  •  clinical trial
  •  deceased persons
  •  non clinical, involving persons
  •  personal data/biological material
  • Apply
Category
Study phase (clinical trials only)
  •  n/a
  •  phase 1
  •  phase 1/2
  •  phase 2
  •  phase 3
  •  phase 4
  • Apply
multi- / monocentric
Displaying 1 - 20 of 5920
BASEC ID Project title Sponsor Approval date multi- / monocentric Principal investigator Investigational sites Type of project Study phase (clinical trials only) Category Lead EC Local EC(s)
2016-00033 Human fetal midbrain and inner ear tissues to develop new regenerative therapy forms for Parkinson's disease and hearing loss 17.01.2017 monocentric Prof. Dr. phil. Hans Rudolf Widmer University of Bern, Bern Kantonale Ethikkommission Bern
2016-00175 Etude de l'expression des facteurs de croissances fibroblastiques, mésenchymateux, épithéliaux et endothéliaux dans le poumon de foetus humains sains. 05.04.2016 monocentric Dr Isabelle Ruchonnet-Métrailler Département d'Immunologie et Pathologie, Genève Commission Cantonale d'éthique de la recherche Genève (CCER)
2015-00011 Diagnostic performance of an automated breast ultrasound system (ABUS): a single centre study 12.01.2016 monocentric PD Dr. med. Dr. sc. hum. Andreas Boss Institut für Interventionelle und diagnostische Radiologie USZ, Zürich clinical trial A Kantonale Ethikkommission Zürich
2015-00023 GS-US-326-1100: A Combined Phase 2/3, Double-Blind, Randomized, Placebo-Controlled, Induction and Maintenance Study Evaluating the Safety and Efficacy of GS-5745 in Subjects with Moderately to Severel More ... Gilead Sciences 18.03.2016 multicentric Prof. Dr Gerhard Rogler USZ, Zürich
Gastroenterologische Praxis Balsiger, Seibold & Partner, Bern
USB Gastroenterologie und Hepathologie, Basel
clinical trial phase 2 C Kantonale Ethikkommission Zürich Kantonale Ethikkommission Bern Ethikkommission Nordwest- und Zentralschweiz EKNZ
2015-00031 Double-blind, randomized, placebo-controlled, phase III study on the efficacy and tolerability of a 48-week treatment with two different doses of budesonide effervescent tablets vs. placebo for mainte More ... Dr. Falk Pharma GmbH 25.05.2016 multicentric Dr. med. Alain Schoepfer University Hospital Lausanne/CHUV Division of Gastroenterology and Hepatology, Lausanne
Praxis für Gastroenterologie, Römerstraße 7, CH-4600 Olten
Universitätsklinik Basel Abteilung für Gastroenterolo More ...
clinical trial phase 3 C Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) Ethikkommission Nordwest- und Zentralschweiz EKNZ Kantonale Ethikkommission Zürich
2015-00039 BIOTRONIK – Safety and clinical performance of the self-expanding transcatheter BIOVALVE prosthesis in subjects with severe symptomatic calcified aortic valve stenosis suitable for transfemoral transc More ... BIOTRONIK AG - Clinical Affairs 08.03.2016 monocentric Prof. Dr.med Francesco Maisano UniversitätsSpital Zürich - Klinik für Herz- und Gefässchirurgie, Zürich clinical trial C Kantonale Ethikkommission Zürich
2015-00040 A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled,
Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in
Subjects with Nonalcoholic Steatohepatitis
Intercept Pharma Switzerland GmbH 01.06.2016 multicentric Prof.Dr.Jean-Francois Dufour University Clinic of Visceral Surgery and Medicine, Bern
Kantonsspital St. Gallen, St. Gallen
EPATOCENTRO TICINO, Lugano
clinical trial phase 3 C Kantonale Ethikkommission Bern Ethikkommission Ostschweiz (EKOS) Comitato etico cantonale Ticino Kantonale Ethikkommission Zürich
2015-00042 SAKK 16/14
Anti-PD-L1 antibody MEDI4736 in addition to neoadjuvant chemotherapy in patients with stage IIIA(N2) non-small cell lung cancer (NSCLC). A multicenter single-arm phase II trial.
SAKK 30.03.2016 multicentric Dr. med. Sacha Rothschild Universitätsspital Basel, Basel
Inselspital Bern, Bern
Spital STS AG Thun, Thun
Hôpitaux Universitaires de Genève, Genève
Kantonspital Aarau, Aarau
Kantonsspital Baden, Baden
Luzerner Kantonsspital, L More ...
clinical trial phase 2 C Ethikkommission Nordwest- und Zentralschweiz EKNZ Kantonale Ethikkommission Bern Ethikkommission Nordwest- und Zentralschweiz EKNZ Commission Cantonale d'éthique de la recherche Genève (CCER) Ethikkommission Ostschweiz (EKOS) Comitato etico cantonale More ...
2015-00043 M13-545: A Phase 3, Randomized, Double-Blind Study Comparing ABT-494 Once Daily Monotherapy to Methotrexate (MTX) Monotherapy in MTX-Naïve Subjects with Moderately to Severely Active Rheumatoid Arthri More ... AbbVie AG 14.03.2016 monocentric Prof. Dr. Jean Dudler Service de rhumatologie HFR Fribourg – Hôpital Cantonal, Fribourg clinical trial phase 3 C Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD)
2015-00044 M13-549: A Phase III, Randomized, Double-Blind Study Comparing ABT-494 to Placebo in Subjects with Moderately to Severely Active Rheumatoid Arthritis Who Are on a Stable Dose of Conventional Synthetic More ... AbbVie AG 23.02.2016 multicentric Prof. Dr. Jean Dudler HFR Kantonsspital Freiburg, Rheumatologie, 1708 Freiburg
Kantonsspital Aarau, Abteilung Rheumatologie, Aarau
clinical trial phase 3 C Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) Ethikkommission Nordwest- und Zentralschweiz EKNZ
2015-00057 GA29144 - A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF
ETROLIZUMAB AS AN INDUCTION AND MAINTENANCE TREATMENT FOR PATIENTS WITH MO More ...
F. Hoffmann-La Roche Ltd. 15.03.2016 multicentric Prof. Dr. Stephan Brand Kantonsspital St. Gallen, St. Gallen
Inselspital Bern, Bern
Crohn-Colitis Zentrum Bern, Bern
clinical trial phase 3 C Ethikkommission Ostschweiz (EKOS) Kantonale Ethikkommission Bern Kantonale Ethikkommission Zürich
2015-00059 Sienna+® Injection Time Pilot Study: A prospective observational multicentre, controlled clinical trial to evaluate the performance of superparamagnetic iron oxide vs. standard technique as tracer in More ... 05.10.2016 multicentric PD Dr. Cornelia Leo Kantonsspital Baden AG, Baden
Universitätsklinik für Frauenheilkunde, Inselspital, Bern
clinical trial A Ethikkommission Nordwest- und Zentralschweiz EKNZ Kantonale Ethikkommission Bern
2015-00068 Responsiveness of the German Version of the Neck Disability Index (NDI-G) 28.01.2016 monocentric Dr. Jaap Swaneburg Balgrist University Clinic, Zurich clinical trial A Kantonale Ethikkommission Zürich
2015-00079 Therapeutic drug monitoring of new generation antiepileptic drugs: concrete benefit, correlation with clinical effects and usefulness of saliva samples 10.05.2016 monocentric Dr Jan Novy CHUV, Lausanne clinical trial A Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD)
2015-00091 EDO-S101-1001: A Phase 1 Study to Investigate the Safety, Pharmacokinetic Profiles and the Efficacy of EDO-S101, a First-in-Class Alkylating Histone Deacetylase Inhibition (HDACi) Fusion Molecule, in More ... Mundipharma EDO GmbH 02.02.2016 monocentric Prof. Dr. med. / Christoph / Driessen Haematologie/Onkologie Kantonsspital, St. Gallen clinical trial phase 1 C Ethikkommission Ostschweiz (EKOS)
2015-00095 An open-label, randomized, active-controlled, parallel-group, Phase-3b study of the efficacy, safety, and tolerability of 2 mg aflibercept administered by intravitreal injections using two different t More ... Bayer (Schweiz) AG, PH Medical Department 17.05.2016 multicentric Prof. Dr. Justus Garweg Berner Augenklinik am Lindenhofspital, Bern
Inselspital – Universitätsspital Bern - Universitätsklinik für Augenheilkunde, Bern
Centre Ophtalmologique de Rive, Genève
clinical trial phase 3 B Kantonale Ethikkommission Bern Commission Cantonale d'éthique de la recherche Genève (CCER)
2015-00119 A Randomized, Multi-center Phase III Study of Nivolumab versus Sorafenib as First-Line Treatment in Patients with Advanced Hepatocellular Carcinoma (CheckMate 459: CHECKpoint pathway and nivoluMAb cli More ... Bristol-Myers Squibb International Corporation 06.04.2016 multicentric Ms. Prof. Dr. Viviane Hess Universitätsspital Basel, Basel
Inselspital BHH, Bern
clinical trial phase 3 B Ethikkommission Nordwest- und Zentralschweiz EKNZ Kantonale Ethikkommission Bern
2015-00120 ABSORB bioresorbable scaffold vs. Xience metallic stent for prevention of restenosis following percutaneous coronary intervention in patients at high risk of restenosis Centre for International Research Initiatives in Cardiovascular Medicine (CERIC) 19.10.2016 multicentric Prof. Stéphane Cook Hôpital Fribourgeois, Fribourg
Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne
clinical trial A Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) Kantonale Ethikkommission Zürich
2015-00121 HPV self-sampling as a test of cure after treatment of cervical intraepithelial neoplasia Hôpitaux Universitaires de Genève 18.02.2016 monocentric Dre. Manuela Viviano Hôpitaux Universitaires de Genève, Genève, Suisse clinical trial A Commission Cantonale d'éthique de la recherche Genève (CCER)
2015-00123 Implementation of the non-invasive cardiac monitoring device "ICON" for the initial evaluation and monitoring of hemodynamics in trauma patients: a feasibility study. 17.05.2016 monocentric PD Dr. med. Beat Schnüriger Inselspital, Bern University Hospital, Bern clinical trial A Kantonale Ethikkommission Bern